Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)
Title:
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)
Author:
Rummel, M. Kim, T.M. Aversa, F. Brugger, W. Capochiani, E. Plenteda, C. Re, F. Trask, P. Osborne, S. Smith, R. Grigg, A.